Complexité de l’adhésion à l’endocrinothérapie adjuvante après un cancer du sein

Leah K. Lambert, Lynda G. Balneaves, A. Fuchsia Howard

Abstract


Chez les femmes atteintes d’un cancer du sein à récepteurs hormonaux positifs, l’endocrinothérapie adjuvante est très efficace pour réduire le risque de récidive et de mortalité. Pourtant, ce ne sont pas toutes les femmes qui se conforment au traitement. L’objectif principal de cette recherche était de mieux comprendre pourquoi de nombreuses femmes ayant reçu un diagnostic de cancer du sein n’adhèrent pas au traitement adjuvant. Une approche méthodologique mixte a été utilisée afin d’explorer les facteurs personnels, sociaux et structurels qui influencent l’adhésion à l’endocrinothérapie adjuvante chez les survivantes du cancer du sein. L’approche comprend : 1) une revue intégrative des facteurs mentionnés par les patientes pour expliquer l’adhésion au traitement endocrinien; et 2) des entretiens avec des survivantes du cancer du sein à qui on a prescrit le traitement adjuvant. Le présent article résume et présente les principales contributions des deux phases de cette recherche, les implications pour la pratique clinique et la manière dont nous pourrons tirer parti de l’expertise des infirmières en les amenant à exercer pleinement leur pratique pour répondre aux besoins complexes des survivantes du cancer du sein à qui l’on prescrit l’endocrinothérapie adjuvante.


Full Text:

PDF

References


Albert, U.-S., Zemlin, C., Hadji, P., Ziller, V., Kuhler, B., Frank-Hahn, B., Wagner, U., & Kalder, M. (2011). The impact of breast care nurses on patients’ satisfaction, understanding of the disease, and adherence to adjuvant endocrine therapy. Breast Care, 6(3), 221–226. https://doi.org/10.1159/000329006

Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine, 353(17), 1784–1792. https://doi.org/10.1097/01.ogx.0000201966.23445.91

Brauer, E. R., Ganz, P. A., & Pieters, H. C. (2016). “Winging it”: How older breast cancer survivors persist with aromatase inhibitor treatment. Journal of Oncology Practice, 12(12), e991–e1000. https://doi.org/10.1200/JOP.2016.011767

Brenner, D. R., Weir, H. K., Demers, A. A., Ellison, L. F., Louzado, C., Shaw, A., Turner, D., Woods, R. R., & Smith, L. M. (2020). Projected estimates of cancer in Canada in 2020. CMAJ, 192(9), E199–E205. https://doi.org/10.1503/cmaj.191292

Bright, E. E., Petrie, K. J., Partridge, A. H., & Stanton, A. L. (2016). Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer. Breast Cancer Research and Treatment, 158(2), 243–251. http://dx.doi.org/10.1007/s10549-016-3871-3

Bryant-Lukosius, D., Cosby, R., Bakker, D., Earle, C., Fitzgerald, B., & Burkoski, V. (2015). Effective use of advanced practice nurses in the delivery of adult cancer services in Ontario (Program in Evidence-Based Care Guideline No. 16-4).

Burstein, H. J., Lacchetti, C., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. A., Giordano, S. H., Hudis, C. A., Solky, A. J., Stearns, V., Winer, E. P., & Griggs, J. J. (2019). Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. Journal of Clinical Oncology, 37(5), 423–438. https://doi.org/10.1200/JCO.18.01160

Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., & Malin, J. (2010). American society of clinical oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. Journal of Clinical Oncology, 28(23), 3784–3796. https://doi.org/10.1200/JCO.2009.26.3756

Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Rowden, D., Solky, A. J., Stearns, V., Winer, E. P., & Griggs, J. J. (2014). Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. Journal of Clinical Oncology, 32(21), 2255–2269. https://doi.org/10.1200/JCO.2013.54.2258

Cahir, C., Dombrowski, S. U., Kelly, C. M., Kennedy, M. J., Bennett, K., & Sharp, L. (2015). Women’s experiences of hormonal therapy for breast cancer: Exploring influences on medication-taking behaviour. Supportive Care in Cancer, 23(11), 3115–3130. https://doi.org/10.1007/s00520-015-2685-x

Cahir, C., Guinan, E., Dombrowski, S. U., Sharp, L., & Bennett, K. (2015). Identifying the determinants of adjuvant hormonal therapy medication taking behaviour in women with stages I–III breast cancer: A systematic review and meta-analysis. Patient Education and Counseling, 98(12), 1524–1539. https://doi.org/10.1016/j.pec.2015.05.013

Canadian Cancer Society’s Steering Committee. (2010). Canadian cancer statistics 2010 (Issue April).

Canadian Nurses Association. (2008). Advanced nursing practice: A national framework.

DiCenso, D. F., Bryant-Lukosius, D., Carter, N., & Harbman, P. (2014). A systematic review of the effectiveness and cost-effectiveness of nurse practitioners and clinical nurse specialists.

Donchin, A. (1995). Reworking autonomy: Toward a feminist perspective. Cambridge Quarterly of Healthcare Ethics, 4, 44–55.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. The Lancet, 378(9793), 771–784. https://doi.org/10.1016/S0140-6736(11)60993-8

Ekinci, E., Nathoo, S., Korattyil, T., Vadhariya, A., Zaghloul, H. A., Niravath, P. A., Abughosh, S. M., & Trivedi, M. V. (2018). Interventions to improve endocrine therapy adherence in breast cancer survivors: What is the evidence? Journal of Cancer Survivorship, 12(3), 348–356. https://doi.org/10.1007/s11764-017-0674-4

Farias, A. J., Ornelas, I. J., Hohl, S. D., Zeliadt, S. B., Hansen, R. N., Li, C. I., & Thompson, B. (2017). Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: A qualitative analysis. Supportive Care in Cancer, 25(1), 75–83. https://doi.org/10.1007/s00520-016-3389-6

Harrow, A., Dryden, R., McCowan, C., Radley, A., Parsons, M., Thompson, A. M., & Wells, M. (2014). A hard pill to swallow: A qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer. BMJ Open, 4(6), e005285. https://doi.org/10.1136/bmjopen-2014-005285

Hershman, D. L., Kushi, L. H., Hillyer, G. C., Coromilas, E., Buono, D., Lamerato, L., Bovbjerg, D. H., Mandelblatt, J. S., Tsai, W.-Y., Zhong, X., Jacobson, J. S., Wright, J. D., & Neugut, A. I. (2016). Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: The breast cancer quality of care study (BQUAL). Breast Cancer Research and Treatment, 157(1), 133–143. https://doi.org/10.1007/s10549-016-3788-x

Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010). Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Journal of Clinical Oncology, 28(27), 4120–4128. https://doi.org/10.1200/JCO.2009.25.9655

Hershman, D. L., Shao, T., Kushi, L., Buono, D., Tsai, W., Fehrenbacher, L., Kwan, M., Gomez, S., & Neugut, A. I. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126(2), 529–537. https://doi.org/10.1007/s10549-010-1132-4

Horrocks, S., Anderson, E., & Salisbury, C. (2002). Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ (Clinical Research Ed.), 324(7341), 819–823. https://doi.org/10.1136/BMJ.324.7341.819

Housden, L. M., Wong, S. T., & Dawes, M. (2013). Effectiveness of group medical visits for improving diabetes care: A systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, 185(13), E635-44. https://doi.org/10.1503/cmaj.130053

Humphries, B., Collins, S., Guillaumie, L., Lemieux, J., Dionne, A., Provencher, L., Moisan, J., Lauzier, S., Humphries, B., Collins, S., Guillaumie, L., Lemieux, J., Dionne, A., Provencher, L., Moisan, J., & Lauzier, S. (2018). Women’s beliefs on early adherence to adjuvant endocrine therapy for breast cancer: A theory-based qualitative study to guide the development of community pharmacist interventions. Pharmacy, 6(2), 53. https://doi.org/10.3390/pharmacy6020053

Kini, V., & Ho, P. M. (2018). Interventions to improve medication adherence. JAMA, 320(23), 2461. https://doi.org/10.1001/jama.2018.19271

Lambert, L. K., Balneaves, L. G., Howard, A. F., Chia, S. K., & Gotay, C. C. (2018a). Understanding adjuvant endocrine therapy persistence in breast cancer survivors. BMC Cancer, 18(1), 732–745. https://doi.org/10.1186/s12885-018-4644-7

Lambert, L. K., Balneaves, L. G., Howard, A. F., Chia, S. K., & Gotay, C. C. (2018b). Understanding adjuvant endocrine therapy persistence in breast cancer survivors. BMC Cancer, 18(1), 732–745. https://doi.org/10.1186/s12885-018-4644-7

Lambert, L. K., Balneaves, L. G., Howard, A. F., & Gotay, C. C. (2018). Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: An integrative review. Breast Cancer Research and Treatment, 167(3). https://doi.org/10.1007/s10549-017-4561-5

Mackenzie, C., & Stoljar, N. (2000). Introduction: Autonomy Reconfigured. In C. Mackenzie & N. Stoljar (Eds.), Relational autonomy: Feminist perspectives on autonomy, agency and the social self (pp. 3–31). Oxford University Press.

Martin-Misener, R., Harbman, P., Donald, F., Reid, K., Kilpatrick, K., Carter, N., Bryant-Lukosius, D., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., & DiCenso, A. (2015). Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: Systematic review. BMJ Open, 5(6), e007167. https://doi.org/10.1136/bmjopen-2014-007167

Mathes, T., Antoine, S.-L., Pieper, D., & Eikermann, M. (2014). Adherence enhancing interventions for oral anticancer agents: A systematic review. Cancer Treatment Reviews, 40(1), 102–108. https://doi.org/10.1016/J.CTRV.2013.07.004

Moon, Z., Moss-Morris, R., Hunter, M. S., Carlisle, S., & Hughes, L. D. (2017). Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: A systematic review. Patient Preference and Adherence, 11, 305–322. https://doi.org/10.2147/PPA.S126651

Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012). Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review. Breast Cancer Research and Treatment, 134(2), 459–478. https://doi.org/doi:10.1007/s10549-012-2114-5

Newhouse, R. P., Stanik-Hutt, J., White, K. M., Johantgen, M., & Bass, E. B. (2011). Advanced practice nurse outcomes 1990-2008: A systematic review. Nursing Econ, 29, 230–250.

Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., & Haynes, R. B. (2014). Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews, 11(11), CD000011. https://doi.org/10.1002/14651858.CD000011.pub4

Shenkier, T., Lohrisch, C., Simmons, C., Dotts, A., McTaggart-Cowan, H., Houlihan, E., Johnston, C., Le, D., Gelmon, K., & Chia, S. (2019). After breast cancer: A nurse practitioner led model of care for women on adjuvant endocrine treatment. Annals of Oncology, 30, iii67. https://doi.org/10.1093/annonc/mdz101.008

Sherwin, S. (1998). A relational approach to autonomy in health care. In S. Sherwin (Ed.), The politics of women’s health: Exploring agency and autonomy (pp. 19–47). Temple University Press.

Sherwin, S. (2011). Looking backwards, looking forward: Hopes for bioethics’ next twenty-five years. Bioethics, 25(2), 75–82. https://doi.org/10.1111/j.1467-8519.2010.01866.x

Stanton, A. L., Petrie, K. J., & Partridge, A. H. (2014). Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Research and Treatment, 145(2), 525–534. https://doi.org/10.1007/s10549-014-2961-3

Sussman, J., Souter, L., Grunfeld, E., Howell, D., Gage, C., Keller-Olaman, S., & Fletcher, G. (2017). Models of care for cancer survivorship.

Trento, M., Passera, P., Borgo, E., Tomalino, M., Bajardi, M., Brescianini, A., Tomelini, M., Giuliano, S., Cavallo, F., Miselli, V., Bondonio, P., & Porta, M. (2005). A 3-year prospective randomized controlled clinical trial of group care in Type 1 diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 15(4), 293–301. https://doi.org/10.1016/J.NUMECD.2004.12.005

Trotter, K., & Schneider, S. M. (2012). Evaluation of a breast cancer survivorship clinic that uses a group medical appointment model: Patient program evaluation and financial analysis. Journal of Clinical Oncology, 30(27_suppl), 90–90. https://doi.org/10.1200/jco.2012.30.27_suppl.90

Van Liew, J. R., Christensen, A. J., & de Moor, J. S. (2014). Psychosocial factors in adjuvant hormone therapy for breast cancer: An emerging context for adherence research. Journal of Cancer Survivorship, 8(3), 521–531. https://doi.org/10.1007/s11764-014-0374-2

Vlahadamis, A., Danilak, M., Rawson, K. M., King, K. M., & Pituskin, E. (2013). Group medical appointments: A novel approach in patient education for adjuvant endocrine therapy. Journal of Clinical Oncology, 31(26_suppl), 133–133. https://doi.org/10.1200/jco.2013.31.26_suppl.133

Wells, K. J., Pan, T. M., Vázquez-Otero, C., Ung, D., Ustjanauskas, A. E., Muñoz, D., Laronga, C., Roetzheim, R. G., Goldenstein, M., Carrizosa, C., Nuhaily, S., Johnson, K., Norton, M., Sims, E., & Quinn, G. P. (2016). Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: A qualitative study. Supportive Care in Cancer, 24(10), 4123–4130. https://doi.org/10.1007/s00520-016-3229-8

Wengstrom, Y. (2008). Effectively nursing patients receiving aromatase inhibitor therapy. The Breast, 17, 227–238. https://doi.org/10.1016/j.breast.2007.11.001


Refbacks

  • There are currently no refbacks.